EW vs EXPD · P/E 47, rev $1.39B vs P/E 26, rev $10.60B
Edwards Lifesciences Corp (EW) versus Expeditors International of Washington, Inc. (EXPD) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
EW currently screens at market cap $49.91B and trailing P/E 46.9. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Not investment advice. Open the EW and EXPD stock pages for the full models.
Not investment advice.